Botanical species · safety record

Aspidosperma quebracho-blanco

The EFSA Compendium of Botanicals holds 24 constituent measurements and 1 adverse-effect record for Aspidosperma quebracho-blanco. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Aspidosperma quebracho-blanco Schltdl.

24Constituent measurements
1Safety records
16Cited sources
5Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 5 licensed products naming Aspidosperma quebracho-blanco as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Bark

What the records describe

Constituents measured

  • Aspidospermine4
  • Alkaloids3
  • Aspidospermatin3
  • Indole alkaloids3
  • Quebrachamine3
  • Quebrachidine2
  • Tannins2
  • Yohimbine2
  • Aspidospermatidine1
  • N-methylaspidospermatidine1

Plant parts

  • Bark11
  • Unspecified8
  • Leaves6

Preparations

  • Solvent extraction14

Effect types

  • Neurotoxicity1

Target tissues

  • Neurologic: central nervous system1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsBarkSolvent extractionGC-MSResolve DOI
AlkaloidsLeavesSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
AspidospermatidineBarkSolvent extractionGC-MSResolve DOI
AspidospermatinBarkSolvent extractionGC-MSResolve DOI
AspidospermineLeavesSolvent extractionIR and Raman SpectroscopyResolve DOI
AspidospermineBarkSolvent extractionGC-MSResolve DOI
QuebrachamineBarkSolvent extractionGC-MSResolve DOI
QuebrachidineLeavesSolvent extractionIR and Raman SpectroscopyResolve DOI
YohimbineBarkSolvent extractionGC-MSResolve DOI
AlkaloidsBarkSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
AspidospermatinUnspecifiedUnspecifiedNo resolvable identifier
AspidospermatinUnspecifiedUnspecifiedNo resolvable identifier
AspidospermineUnspecifiedUnspecifiedNo resolvable identifier
AspidospermineBarkMass Spectroscopy and hyphenated methods without chromatographyNo resolvable identifier
Indole alkaloidsUnspecifiedUnspecifiedNo resolvable identifier
Indole alkaloidsUnspecifiedUnspecifiedNo resolvable identifier
Indole alkaloidsBarkSolvent extractionGC-MSNo resolvable identifier
N-methylaspidospermatidineUnspecifiedUnspecifiedNo resolvable identifier
QuebrachamineUnspecifiedUnspecifiedNo resolvable identifier
QuebrachamineBarkMass Spectroscopy and hyphenated methods without chromatographyNo resolvable identifier
QuebrachidineUnspecifiedUnspecifiedNo resolvable identifier
TanninsLeavesSolvent extraction1.81 PercentUnspecifiedNo resolvable identifier
TanninsLeavesSolvent extraction1.87 PercentUnspecifiedNo resolvable identifier
YohimbineBarkSolvent extraction44 Milligram/100 gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
NeurotoxicityNeurologic: central nervous systemLeavesHouse mouse (as animal)Acute toxicityResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Wishart, DS., Jewison, T., Guo, AC., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., Bouatra, S., Sinelnikov, I., Arndt, D., Xia, J., Liu, P., Yallou, F., Bjorndahl, T., Perez-Pineiro, R., Eisner, R., Allen, F., Neveu, V., Greiner, R., Scalbert, A. (-)-Quebrachamine (HMDB30260). Human metabolome database, 2012.
  2. LYON, RL., FONG, HHS., FARNSWORTH, NR., SVOBODA, GH. BIOLOGICAL AND PHYTOCHEMICAL EVALUATION OF PLANTS .9. ISOLATION OF ASPIDOSPERMINE, QUEBRACHIDINE, RHAZINILAM, (-)-PYRIFOLIDINE, AND AKUAMMIDINE FROM ASPIDOSPERMA-QUEBRACHO-BLANCO (APOCYNACEAE) . Journal of pharmaceutical sciences, 1973, vol. 62, no. 2, p. 218-221. DOI
  3. Wishart, DS., Jewison, T., Guo, AC., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., Bouatra, S., Sinelnikov, I., Arndt, D., Xia, J., Liu, P., Yallou, F., Bjorndahl, T., Perez-Pineiro, R., Eisner, R., Allen, F., Neveu, V., Greiner, R., Scalbert, A. (+)-Quebrachidine (HMDB30390). Human metabolome database, 2012.
  4. Prado, Luis L., Ricci, Enzo. Systematic study of the tannin content of various indigenous species. Anales admin. nacl. bosques, rep. arg., 1956, p. 7-17.
  5. BIEMANN, K., SPITELLER, G., SPITELLERFRIEDMANN, M. APPLICATION OF MASS SPECTROMETRY TO STRUCTURE PROBLEMS .10. ALKALOIDS OF BARK OF ASPIDOSPERMA QUEBRACHO BLANCO . Journal of the american chemical society, 1963, vol. 85, no. 5, p. 631-&. DOI
  6. Wilson, E., Palacios, P., Rondina, R. V. D., Coussio, J. D. Determination of yohimbine in bark isolated from Aspidosperma quebracho blanco Schlecht. Revista farmaceutica (buenos aires), 1983, vol. 125(1-4), p. 9-11.
  7. Wishart, DS., Jewison, T., Guo, AC., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., Bouatra, S., Sinelnikov, I., Arndt, D., Xia, J., Liu, P., Yallou, F., Bjorndahl, T., Perez-Pineiro, R., Eisner, R., Allen, F., Neveu, V., Greiner, R., Scalbert, A. (-)-Aspidospermine (HMDB30361). Human metabolome database, 2012.
  8. Wishart, DS., Jewison, T., Guo, AC., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., Bouatra, S., Sinelnikov, I., Arndt, D., Xia, J., Liu, P., Yallou, F., Bjorndahl, T., Perez-Pineiro, R., Eisner, R., Allen, F., Neveu, V., Greiner, R., Scalbert, A. (+)-Aspidospermidine (HMDB30360). Human metabolome database, 2012.
  9. Wishart, DS., Jewison, T., Guo, AC., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., Bouatra, S., Sinelnikov, I., Arndt, D., Xia, J., Liu, P., Yallou, F., Bjorndahl, T., Perez-Pineiro, R., Eisner, R., Allen, F., Neveu, V., Greiner, R., Scalbert, A. 14,19-Didehydrocondyfolan (HMDB30356). Human metabolome database, 2012.
  10. Schnoes, H.K., Burlingame, A.L., Biemann, K. Application of mass spectrometry to structure problems: the occurrence of eburnamenine and related alkaloids in Rhazya stricta and Aspidosperma quebracho blanco. Tetrahedron letters, 1962, vol. 3, no. 22, p. 993-999.
  11. Wishart, DS., Jewison, T., Guo, AC., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., Bouatra, S., Sinelnikov, I., Arndt, D., Xia, J., Liu, P., Yallou, F., Bjorndahl, T., Perez-Pineiro, R., Eisner, R., Allen, F., Neveu, V., Greiner, R., Scalbert, A. N-Methylaspidospermatidine (HMDB30357). Human metabolome database, 2012.
  12. Biemann, K., Spiteller, G. Application of mass spectrometry to structure problems. VIII. Quebrachamine. Journal of the american chemical society, 1962, vol. 84, p. 4578-86.
  13. BENOIT, PS., ANGRY, G., LYON, RL., FONG, HHS., FARNSWORTH, NR. BIOLOGICAL AND PHYTOCHEMICAL EVALUATION OF PLANTS .13. PRELIMINARY ESTIMATION OF ANALGESIC ACTIVITY OF RHAZINILAM, A NOVEL ALKALOID ISOLATED FROM ASPIDOSPERMA-QUEBRACHO-BLANCO LEAVES . Journal of pharmaceutical sciences, 1973, vol. 62, no. 11, p. 1889-1889. DOI
  14. Markey, S., Biemann, Klaus., Witkop, Bernhard. Isolation of rhazidine and akuammidine from Aspidosperma quebracho-blanco. Structure of rhazidine. Tetrahedron letters, 1967, vol. (2), p. 157-60.
  15. Wishart, DS., Jewison, T., Guo, AC., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., Bouatra, S., Sinelnikov, I., Arndt, D., Xia, J., Liu, P., Yallou, F., Bjorndahl, T., Perez-Pineiro, R., Eisner, R., Allen, F., Neveu, V., Greiner, R., Scalbert, A. 14,19-Dihydroaspidospermatine (HMDB30359). Human metabolome database, 2012.
  16. Wishart, DS., Jewison, T., Guo, AC., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., Bouatra, S., Sinelnikov, I., Arndt, D., Xia, J., Liu, P., Yallou, F., Bjorndahl, T., Perez-Pineiro, R., Eisner, R., Allen, F., Neveu, V., Greiner, R., Scalbert, A. Aspidospermatine (HMDB30358). Human metabolome database, 2012.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue